Mesenchymal stromal cells (MSCs) display heterogeneity in origin and functional role in tissue homeostasis. Subsets of MSCs derived from the neural crest express nestin and serve as niches in bone marrow, but the possibility of coaxing MSCs into nestin-expresing cells for enhanced supportive activity is unclear. In this study, as an approach to the chemical coaxing of MSC functions, we screened libraries of clinically approved chemicals to identify compounds capable of inducing nestin expression in MSCs. Out of 2000 clinical compounds, we chose vorinostat as a candidate to coax the MSCs into neural crest-like fates. When treated with vorinostat, MSCs exhibited a significant increase in the expression of genes involved in the pluripotency and epithelial-mesenchymal transition (EMT), as well as nestin and CD146, the markers for pericytes. In addition, these nestin-induced MSCs exhibited enhanced differentiation towards neuronal cells with the upregulation of neurogenic markers, including SRY-box transcription factor 2 (Sox2), SRY-box transcription factor 10 (Sox10) and microtubule associated protein 2 (Map2) in addition to nestin. Moreover, the coaxed MSCs exhibited enhanced supporting activity for hematopoietic progenitors without supporting leukemia cells. These results demonstrate the feasibility of the drug repositioning of MSCs to induce neural crest-like properties through the chemical coaxing of cell fates.

The electrochemical conversion of carbon dioxide (CO2) to valuable chemicals is gaining significant attention as a pragmatic solution for achieving carbon neutrality and storing renewable energy in a usable form. Recent research increasingly focuses on designing electrocatalysts that specifically convert CO2 into ethanol, a desirable product due to its high-energy density, ease of storage, and portability. However, achieving high-efficiency ethanol production remains a challenge compared to ethylene (a competing product with a similar electron configuration). Existing electrocatalytic systems often suffer from limitations such as low energy efficiency, poor stability, and inadequate selectivity toward ethanol. Inspired by recent progress in the field, this review explores fundamental principles and material advancements in CO2 electroreduction, emphasizing strategies for ethanol production over ethylene. We discuss electrocatalyst design, reaction mechanisms, challenges, and future research directions. These advancements aim to bridge the gap between current research and industrialized applications of this technology.

Oligonucleotide therapeutics, a pioneering category of modern medicinal drugs, are at the forefront of utilizing innate mechanisms to modulate gene expression. With 18 oligonucleotide-based FDA-approved medicines currently available for treating various clinical conditions, this field showcases an innovative potential yet to be fully explored. Factors such as purity, formulation, and endotoxin levels profoundly influence the efficacy and safety of these therapeutics. Therefore, a thorough understanding of the chemical factors essential for producing high-quality oligonucleotides for preclinical studies is crucial in their development for further clinical application. This paper serves as a concise guide to these chemical considerations, aiming to inspire and equip researchers with the necessary knowledge to advance in this exciting and innovative field.

Pulsed electrolysis has emerged as a promising approach to CO2 reduction, offering a simple method to adjust product selectivity and enhance operational stability. However, conceptually applying the dynamic pulse operation process on a large scale highlights its differences when compared to conventional electrolysis processes, impacting the economic feasibility of the process. We discuss the influence of pulsed electrolysis on surface reaction mechanisms and the simulation of changes at both the continuum and smaller scales through computational modeling. Additionally, we point out considerations for applying pulsed CO2 electrolysis to a large-scale process and assess their economic implications, comparing pulsed electrolysis with constant electrolysis.

Hydrogen is a promising combustion improver for use with ammonia fuels, but a cost-effective method for easily producing hydrogen from ammonia at a high rate has yet to be developed. Here, we show that microwave irradiation instantly triggers oxidative decomposition of ammonia over a Co/Ce0.5Zr0.5O2 catalyst to produce hydrogen at a high rate. The microwave irradiation rapidly heats the inside of the catalyst from room temperature to the catalytic auto-ignition temperature of ammonia, thus initiating exothermic oxidative decomposition of ammonia to produce hydrogen. This method provides a highly efficient means of producing hydrogen for potential use in a carbon-free, ammonia-fueled power generation process.

Metal-organic frameworks (MOFs) are functional materials that are proving to be indispensable for the development of next-generation batteries. The porosity, crystallinity, and abundance of active sites in MOFs, which can be tuned by selecting the appropriate transition metal/organic linker combination, enable MOFs to meet the performance requirements for cathode materials in batteries. Recent studies on the use of MOFs in cathodes have verified their high durability, cyclability, and capacity thus demonstrating the huge potential of MOFs as high-performance cathode materials. However, to keep pace with the rapid growth of the battery industry, several challenges hindering the development of MOF-based cathode materials need to be overcome. This review analyzes current applications of MOFs to commercially available lithium-ion batteries as well as advanced batteries still in the research stage. This review provides a comprehensive outlook on the progress and potential of MOF cathodes in meeting the performance requirements of the future battery industry.

Aqueous zinc-ion batteries (AZIBs) have garnered considerable interest as potential solutions for large-scale energy storage systems, owing to their cost-effectiveness and high safety. Nonetheless, the development of AZIBs is hindered by significant challenges associated with dendrite growth and side reactions on Zn anodes. Here, a bio-based separator derived from cellulose was developed for the dendrite-free anode in AZIBs. In addition, the separator is notable for its ultra-low cost and biodegradability in contrast to the commonly used commercial glass fiber (GF) separators. The mechanical strength of the separator is enhanced by the cross-linking of hydrogen bonds, effectively inhibiting dendrite growth. The zinc-philic groups facilitate better binding to Zn2+, resulting in uniform nucleation and deposition. The hydrophilic groups aid in trapping water molecules, thereby preventing side reactions of the electrolyte. The Zn||Zn symmetric cell with this separator can sustain a long cycle life for over 800 h, indicating stable Zn2 + plating and stripping with suppressed dendrite growth. Concurrently, the assembled Zn||VO2 full batteries exhibited a capacity retention rate of 61.87% after 1,000 cycles at 1 A g-1 with an initial capacity of 140 mAh g-1. This work highlights a stable, economical, and eco-friendly approach to the design of bio-based separators in AZIBs for sustainable energy storage systems.

Exosomes are nanoscale membrane bound vesicles secreted by almost all types of cells. Their unique attributes, such as minimal immunogenicity and compatibility with biological systems, make them novel carriers for drug delivery. These native exosomes harbor proteins, nucleic acids, small molecule compounds, and fluorogenic agents. Moreover, through a combination of chemical and bioengineering methodologies, exosomes are tailored to transport precise therapeutic payloads to designated cells or tissues. In this review, we summarize the strategies for exosome modification and drug loading modalities in engineered exosomes. In addition, we provide an overview of the advances in the use of engineered exosomes for targeted drug delivery. Lastly, we discuss the merits and limitations of chemically engineered versus bioengineered exosome-mediated target therapies. These insights offer additional options for refining engineered exosomes in pharmaceutical development and hold promise for expediting the successful translation of engineered exosomes from the bench to the bedside.

We have developed an eco-friendly and efficient method for hydrovoltaic power generation through carbonizing natural kelp, a hydrogel with abundant cations. Under ambient conditions, a CO2 laser beam was focused on the top surface of dried kelp, photothermally converting it into porous graphitic carbon (PGC) and reducing dissociable cations by thermal evaporation. Owing to the preservation of the bottom surface, this photothermal process yielded a PGC-hydrogel membrane (PHM) featuring a cation concentration gradient. With the introduction of deionized water to the intact region, the kelp hydrogel retained a considerable volume of water, creating a moist environment for the PGC. The cation concentration gradient facilitated a continuous migration of cations between the PGC and unaltered kelp, generating a voltage of 0.34 V and a current density of 49 μA/cm2. We demonstrated its practical applicability by turning on three light-emitting diodes using an array of eight PHMs.

Compared with the conventional emulsification method, droplets generated within microfluidic devices exhibit distinct advantages such as precise control of fluids, exceptional monodispersity, uniform morphology, flexible manipulation, and narrow size distribution. These inherent benefits, including intrinsic safety, excellent heat and mass transfer capabilities, and large surface-to-volume ratio, have led to the widespread applications of droplet-based microfluidics across diverse fields, encompassing chemical engineering, particle synthesis, biological detection, diagnostics, emulsion preparation, and pharmaceuticals. However, despite its promising potential for versatile applications, the practical utilization of this technology in commercial and industrial is extremely limited to the inherently low production rates achievable within a single microchannel. Over the past two decades, droplet-based microfluidics has evolved significantly, considerably transitioning from a proof-of-concept stage to industrialization. And now there is a growing trend towards translating academic research into commercial and industrial applications, primarily driven by the burgeoning demands of various fields. This paper comprehensively reviews recent advancements in droplet-based microfluidics, covering the fundamental working principles and the critical aspect of scale-up integration from working principles to scale-up integration. Based on the existing scale-up strategies, the paper also outlines the future research directions, identifies the potential opportunities, and addresses the typical unsolved challenges.